After a dramatic vote, the Senate pushes ahead on Trump's tax break and spending cut plan
WASHINGTON — Capping a tumultuous night, the Republican-controlled Senate advanced President Donald Trump's package of tax breaks, spending cuts and increased deportation money , with more weekend work ahead as Congress races to meet his Fourth of July deadline for passage.
By a 51-49 tally and with Vice President JD Vance at the Capitol to break a potential tie, the Senate cleared a key procedural step Saturday as midnight approached. Voting had come to a standstill, dragging for more than three hours, with holdout senators huddling for negotiations and taking private meetings off the Senate floor. In the end, two Republicans opposed the motion to move ahead on Trump's signature domestic policy plan , joining all 47 Democrats.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Citi Maintains ‘Neutral' Rating on EchoStar Corporation (SATS); Raises PT
EchoStar Corporation (NASDAQ:SATS) is one of the best stocks for a . The corporate headquarters of a satellite radio systems company, illuminating the skyline. As announced on June 24, 2025, Citi maintained a 'Neutral' rating on EchoStar Corporation (NASDAQ:SATS), raising its price target from $27 to $28.50. The analyst cited its reevaluation of EchoStar's potential value related to its spectrum assets. These assets include the company's licenses for radio frequencies used for communication. Furthermore, Citi expects a strategic update to be announced by the company within 30 days. The analyst highlights its importance as this expected development would come at a critical time, as EchoStar approaches a bond-related interest payment milestone. EchoStar Corporation (NASDAQ:SATS), a U.S.-based telecommunications company, delivers broadband, wireless, and satellite services through its Pay-TV, Retail Wireless, and BSS segments, and is also part of our growth stock portfolio. While we acknowledge the potential of SATS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: 10 Overlooked Tech Stocks to Buy Now and 10 Low Risk High Reward Stocks Set to Triple by 2030. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
BMO Capital Maintains ‘Outperform' Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is among the best stocks added in a . A well-stocked pharmacy shelf full of the company's pharmaceuticals, nutraceuticals, over-the-counter medications, and health care products. BMO Capital maintained an 'Outperform' rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), announcing this on June 24, 2025. The analyst raised its price target on the company's stock from $300 to $360. BMO Capital attributed this update to a drastic increase in Amvuttra sales for ATTR-CM, according to IQVIA tracking data, after the drug's approval in March. Furthermore, the analyst cited the continued consistency of the company's sales trends, reinforcing confidence in its commercial traction. While short-term skepticism exists regarding the company's revenue growth, Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) consistent historical trend of revenue and pipeline growth supports its potential for continued growth. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a biopharmaceutical company, develops and markets RNAi therapeutics for rare and genetic diseases. The company has demonstrated consistent YoY revenue growth, making it part of the growth stock portfolio. While we acknowledge the potential of ALNY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: 10 Best Marketing Stocks to Buy Right Now and 10 Best Cybersecurity Stocks to Invest in Under $20. Disclosure: None.
Politico
31 minutes ago
- Politico
Thom Tillis denounces GOP megabill's Medicaid cuts in fiery speech
Hours after announcing his retirement, Republican Sen. Thom Tillis went to the Senate floor and slammed the GOP's plans for drastic Medicaid cuts — warning Republicans they are about to 'make a mistake on health care and betray a promise' if their sprawing domestic policy bill passes. 'It is inescapable this bill will betray the promise Donald Trump made,' Tillis said. 'I'm telling the president that you have been misinformed. You supporting the Senate mark will hurt people who are eligible and qualified for Medicaid.' Tillis, who opposed the bill on a procedural vote Saturday night and then announced Sunday he would not seek reelection, said he could not vote for the Senate's bill because provisions that he said would kick some 663,000 residents of his state off their health care plans. He called on the Senate GOP to jettison its 'artificial' July 4 deadline and rewrite the bill. 'I respect President Trump, I support the majority of his agenda, but I don't bow to anybody when the people of North Carolina are at risk, and this puts them at risk,' Tillis told reporters after he left the floor. The two-term senator who has been known for working across the aisle said he had done his own research on how changes to so-called state directed payments and a new cap on medical providers taxes would affect his state — contacting state legislative leaders, the state's Democratic governor, Josh Stein and hospital groups. Tillis said he also talked to CMS Director Mehmet Oz and presented his findings that showed the best-case scenario was a $26 billion cut in federal support. 'After three different attempts for them to discredit our estimates, the day before yesterday they admitted that we were right,' Tillis said on the floor. 'They can't find a hole in my estimate.' In his remarks to reporters, he said Trump is 'getting a lot of advice from people who have never governed and all they've done is written white papers,' adding that he has 'people from an ivory tower driving him into a box canyon.' Tillis, who was elected to the Senate in 2014, compared Trump's 'big, beautiful bill' to the Affordable Care Act: 'The effect of this bill is to break a promise. And you know, the last time I saw a promise broken around health care, with respect to my friends on the other side of the aisle is when somebody said, 'If you like your health care, you can keep it.'' The Senate is now working through up to 20 hours of debate, before a marathon voting series of amendments scheduled to start Monday morning. Tillis said he might return to the floor to speak against the bill. Trump lambasted Tillis Saturday night after he voted against opening debate on the megabill, and Tillis said he'd already told Trump at that point he was likely to retire. 'Pretty much what I said on the floor is what I said to the president last night and I stand by it,' Tillis told reporters after the speech, adding later that he told the President he 'probably needed to start looking for a replacement.' 'I told him I want to help him,' Tillis added. 'I hope that we get a good candidate that I can help and we can have a successful 2026.'
